Journal article
Deletion of Myeloid GSK3α Attenuates Atherosclerosis and Promotes an M2 Macrophage Phenotype
Abstract
OBJECTIVE: Glycogen synthase kinase (GSK)-3α/β has been implicated in the pathogenesis of diabetes mellitus, cancer, Alzheimer, and atherosclerosis. The tissue- and homolog-specific functions of GSK3α and β in atherosclerosis are unknown. This study examines the effect of hepatocyte or myeloid cell deletion of GSK3α or GSK3β on atherosclerosis in low-density lipoprotein receptor (LDLR)(-/-) mice.
APPROACH AND RESULTS: We ablated GSK3α or GSK3β …
Authors
McAlpine CS; Huang A; Emdin A; Banko NS; Beriault DR; Shi Y; Werstuck GH
Journal
Arteriosclerosis Thrombosis and Vascular Biology, Vol. 35, No. 5, pp. 1113–1122
Publisher
Wolters Kluwer
Publication Date
5 2015
DOI
10.1161/atvbaha.115.305438
ISSN
1079-5642